"Die Behandlung von Krebserkrankungen erfordert ein hohes Maß an fachlicher Kompetenz und die Bereitschaft, auf die individuellen Bedürfnisse des betroffenen Menschen einzugehen. Mit unserem Behandlungskonzept wollen wir dazu beitragen, dass Sie trotz der Erkrankung nicht nur am, sondern vor allem im Leben bleiben. Eine ambulante onkologische Betreuung ermöglicht Ihnen das Verbleiben im vertrauten Umfeld."

During the past decade, Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie" are "Leukemia" (3 trials), "Lymphoma" (3 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie" in a lesser frequency.

Most popular intervention types in "Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie" are "Drug" (7 trials), "Biological" (5 trials), "Radiation" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (4 trials), "doxorubicin hydrochloride" (3 trials), "filgrastim" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".